Literature DB >> 19688809

FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis.

Youmin Kang1, Jia Zhao, Yue Liu, Aoshuang Chen, Guoxing Zheng, Yang Yu, Jianjie Mi, Qiang Zou, Bin Wang.   

Abstract

BACKGROUND: DNA vaccination is a strategy that has been developed primarily to elicit protective immunity against infection and cancer.
METHODS: DNA vaccine was used, in conjunction with an immunosuppressant, to tolerize harmful autoimmunity.
RESULTS: Immunization of C57BL/6 mice with MOG(35-55), a myelin oligodendrocyte glycoprotein-derived peptide, and FK506 (Tacrolimus) as a tolerogenic adjuvant stimulated regulatory dendritic cells, induced antigen-specific regulatory T cells (Treg), and protected the animals from subsequent induction of experimental autoimmune encephalomyelitis (EAE). After EAE induction, there were fewer lymphocytes, including fewer T helper 17 cells, and more Treg infiltrating the spinal cord in the immunized mice compared to in control mice. Furthermore, at the peak of the EAE manifestation, CD4 T cells in the immunized mice showed decreased expression of interferon-gamma and interleukin (IL)-17, but not IL-4, in treated mice.
CONCLUSIONS: DNA vaccination, when applied with an immunosuppressant as adjuvant, can induce antigen-specific tolerance and prevent autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688809     DOI: 10.1002/jgm.1387

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  10 in total

Review 1.  Vitamin D Deficiency and Rheumatoid Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Marcimara Penitenti; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

2.  Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.

Authors:  Laura Northrup; Joshua O Sestak; Bradley P Sullivan; Sharadvi Thati; Brittany L Hartwell; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  AAPS J       Date:  2014-10-09       Impact factor: 4.009

Review 3.  Harnessing DNA-induced immune responses for improving cancer vaccines.

Authors:  Andrés A Herrada; Nicole Rojas-Colonelli; Paula González-Figueroa; Jonathan Roco; César Oyarce; Maarten A Ligtenberg; Alvaro Lladser
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

4.  Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.

Authors:  Youmin Kang; Yuhan Sun; Jingyao Zhang; Wenjuan Gao; Jingjing Kang; Yongqiang Wang; Bin Wang; Guoliang Xia
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

5.  Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.

Authors:  Fernanda Chiuso-Minicucci; Larissa Lumi Watanabe Ishikawa; Luiza Ayumi Nishiyama Mimura; Thais Fernanda de Campos Fraga-Silva; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Camila Marques; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 6.  Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.

Authors:  Cody D Moorman; Sue J Sohn; Hyewon Phee
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

7.  Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases.

Authors:  Chantal Keijzer; Ruurd van der Zee; Willem van Eden; Femke Broere
Journal:  Front Immunol       Date:  2013-08-20       Impact factor: 7.561

8.  Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.

Authors:  Jingyao Zhang; Wenjuan Gao; Xu Yang; Jingjing Kang; Yongliang Zhang; Qirui Guo; Yanxin Hu; Guoliang Xia; Youmin Kang
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

9.  Helminth protein vaccine induced follicular T helper cell for enhancement of humoral immunity against Schistosoma japonicum.

Authors:  Jingyao Zhang; Wenjuan Gao; Qirui Guo; Bobo Huang; Bin Wang; Guoliang Xia; Youmin Kang
Journal:  Biomed Res Int       Date:  2013-11-06       Impact factor: 3.411

10.  Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.

Authors:  Ya-Hsuan Chao; Der-Yuan Chen; Joung-Liang Lan; Kuo-Tung Tang; Chi-Chien Lin
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.